LCTX · AMEX · Biotechnology

Lineage Cell Therapeutics (LCTX)

Develops off-the-shelf cell-replacement therapies for retinal, spinal-cord, hearing and corneal disease.

$0.9701
vs last close−0.07 (−6.72%)